Form D Raw Data - Electronic Filing Depository

EFDID: 546717EFD: Raw Data

Issuer: 60 DEGREES PHARMACEUTICALS, INC. (0001946563) - D

Accession: 0001946563-25-000001 () (EDGAR Files) (Form D)

Edgar Posted: Feb. 11, 2025
EFD Posted: Feb. 11, 2025

- < edgarSubmission >

< schemaVersion > X0708 </ schemaVersion >

< submissionType > D </ submissionType >

< testOrLive > LIVE </ testOrLive >

- < primaryIssuer >

< cik > 0001946563 </ cik >

< entityName > 60 DEGREES PHARMACEUTICALS, INC. </ entityName >

- < issuerAddress >

< street1 > 1025 CONNECTICUT AVENUE NW </ street1 >

< street2 > SUITE 1000 </ street2 >

< city > WASHINGTON </ city >

< stateOrCountry > DC </ stateOrCountry >

< stateOrCountryDescription > DISTRICT OF COLUMBIA </ stateOrCountryDescription >

< zipCode > 20036 </ zipCode >

</ issuerAddress >

< issuerPhoneNumber > 202-327-5422 </ issuerPhoneNumber >

< jurisdictionOfInc > DELAWARE </ jurisdictionOfInc >

- < issuerPreviousNameList >

< value > None </ value >

</ issuerPreviousNameList >

- < edgarPreviousNameList >

< value > None </ value >

</ edgarPreviousNameList >

< entityType > Corporation </ entityType >

- < yearOfInc >

< withinFiveYears > true </ withinFiveYears >

< value > 2022 </ value >

</ yearOfInc >

</ primaryIssuer >

- < relatedPersonsList >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Geoffrey </ firstName >

< middleName > S. </ middleName >

< lastName > Dow </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 1025 Connecticut Avenue NW </ street1 >

< street2 > Suite 1000 </ street2 >

< city > Washington </ city >

< stateOrCountry > DC </ stateOrCountry >

< stateOrCountryDescription > DISTRICT OF COLUMBIA </ stateOrCountryDescription >

< zipCode > 20036 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

< relationshipClarification > Chief Executive Officer and President </ relationshipClarification >

</ relatedPersonInfo >

</ relatedPersonsList >

- < offeringData >

- < industryGroup >

< industryGroupType > Pharmaceuticals </ industryGroupType >

</ industryGroup >

- < issuerSize >

< revenueRange > Decline to Disclose </ revenueRange >

</ issuerSize >

- < federalExemptionsExclusions >

< item > 06b </ item >

</ federalExemptionsExclusions >

- < typeOfFiling >

- < newOrAmendment >

< isAmendment > false </ isAmendment >

</ newOrAmendment >

- < dateOfFirstSale >

< value > 2025-01-28 </ value >

</ dateOfFirstSale >

</ typeOfFiling >

- < durationOfOffering >

< moreThanOneYear > false </ moreThanOneYear >

</ durationOfOffering >

- < typesOfSecuritiesOffered >

< isOptionToAcquireType > true </ isOptionToAcquireType >

</ typesOfSecuritiesOffered >

- < businessCombinationTransaction >

< isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >

< clarificationOfResponse />

</ businessCombinationTransaction >

< minimumInvestmentAccepted > 0 </ minimumInvestmentAccepted >

- < salesCompensationList >

- < recipient >

< recipientName > H.C.WAINWRIGHT & CO., LLC </ recipientName >

< recipientCRDNumber > 375 </ recipientCRDNumber >

< associatedBDName > None </ associatedBDName >

< associatedBDCRDNumber > None </ associatedBDCRDNumber >

- < recipientAddress >

< street1 > 430 PARK AVENUE </ street1 >

< street2 > 4TH FLOOR </ street2 >

< city > NEW YORK </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10022 </ zipCode >

</ recipientAddress >

- < statesOfSolicitationList >

< state > CT </ state >

< description > CONNECTICUT </ description >

< state > IL </ state >

< description > ILLINOIS </ description >

</ statesOfSolicitationList >

< foreignSolicitation > true </ foreignSolicitation >

</ recipient >

</ salesCompensationList >

- < offeringSalesAmounts >

< totalOfferingAmount > 1043002 </ totalOfferingAmount >

< totalAmountSold > 1043002 </ totalAmountSold >

< totalRemaining > 0 </ totalRemaining >

< clarificationOfResponse />

</ offeringSalesAmounts >

- < investors >

< hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >

< totalNumberAlreadyInvested > 4 </ totalNumberAlreadyInvested >

</ investors >

- < salesCommissionsFindersFees >

- < salesCommissions >

< dollarAmount > 88655 </ dollarAmount >

< isEstimate > true </ isEstimate >

</ salesCommissions >

- < findersFees >

< dollarAmount > 0 </ dollarAmount >

< isEstimate > true </ isEstimate >

</ findersFees >

< clarificationOfResponse > Includes a 1.0% cash fee on gross proceeds from the registered shares paid to HC Wainwright. No separate commission was charged for the warrants, but the fee may be attributed to the private placement of the warrants. </ clarificationOfResponse >

</ salesCommissionsFindersFees >

- < useOfProceeds >

- < grossProceedsUsed >

< dollarAmount > 0 </ dollarAmount >

< isEstimate > true </ isEstimate >

</ grossProceedsUsed >

< clarificationOfResponse />

</ useOfProceeds >

- < signatureBlock >

< authorizedRepresentative > false </ authorizedRepresentative >

- < signature >

< issuerName > 60 DEGREES PHARMACEUTICALS, INC. </ issuerName >

< signatureName > /s/ Geoffrey S. Dow </ signatureName >

< nameOfSigner > Geoffrey S. Dow </ nameOfSigner >

< signatureTitle > President and Chief Executive Officer </ signatureTitle >

< signatureDate > 2025-02-11 </ signatureDate >

</ signature >

</ signatureBlock >

</ offeringData >

</ edgarSubmission >